1. Kharasch, Evan D. 美国 Duke University School of Medicine 2013美国医学院院士 Methadone pharmacogenetics in vitro and in vivo: Metabolism by CYP2B6 polymorphic variants and genet..
2. Kharasch, Evan D. 美国 Duke University School of Medicine 2013美国医学院院士 Toward precision prescribing for methadone: Determinants of methadone deposition
3. Kharasch, Evan D. 美国 Duke University School of Medicine 2013美国医学院院士 Methadone Pharmacogenetics
4. Kharasch, Evan D. 美国 Duke University School of Medicine 2013美国医学院院士 Differences in Methadone Metabolism by CYP2B6 Variants
5. Kharasch, Evan D. 美国 Duke University School of Medicine 2013美国医学院院士 Cytochrome P4503A Does Not Mediate the Interaction between Methadone and Ritonavir-Lopinavir
6. Kharasch, Evan D. 美国 Duke University School of Medicine 2013美国医学院院士 Methadone N-Demethylation by the Common CYP2B6 Allelic Variant CYP2B6.6
7. Kharasch, Evan D. 美国 Duke University School of Medicine 2013美国医学院院士 Role of Cytochrome P4502B6 in Methadone Metabolism and Clearance
8. Bernard,Le Foll 加拿大 University of Toronto Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinic..
9. Rachel Fynvola,Tyndale 加拿大 University of Toronto Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinic..
10. Olav,Spigset 挪威 Norwegian University of Science and Technology Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implication..
11. Franco,Folli 意大利 University of Milan Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4-and CYP2D6-Mediated Metabol..
12. Charles E,Inturrisi 美国 Cornell University Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4-and CYP2D6-Mediated Metabol..
13. Santucci, Annalisa 意大利 University of Siena Supporting Machine Learning Model in the Treatment of Chronic Pain
14. 蔡世仁 中国 台北荣民总医院 Splice-Site Variants in the Gene Encoding GABA-A Receptor Delta Subunit Are Associated with Amphetam..
15. Stephen H,Wright 美国 University of Arizona Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoho..
16. Nathan J,Cherrington 美国 University of Arizona Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoho..
17. 蓝先元 中国 台湾中国医药大学 Association of a Common NOS1AP Variant with Attenuation of QTc Prolongation in Men with Heroin Depen..
18. Flavio,Kapczinski 加拿大 McMaster University Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in ..
19. Lehana,Thabane 加拿大 McMaster University Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in ..
20. Guillaume,Pare 加拿大 McMaster University Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in ..